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Abstract 
Background Compared to the general population, the Traveller community has substantial health 
inequalities. Vaccination coverage in Traveller children is estimated to be low and Travellers are at 
higher risk of vaccine-preventable diseases due to their social circumstances. 
Methods Audit of vaccination history of Traveller (n=214) and non-Traveller (n=776) children 
registered at a General Practice in England. The Green Book childhood immunisation schedule was 
used as a reference standard.  
Results There was significantly lower coverage for Traveller children compared to non-Traveller 
children for all vaccinations in the routine childhood immunisation schedule. The percentage of 
children completing the schedule at all time points was significantly lower in the Traveller 
community.   
Conclusions Traveller communities have significantly lower uptake of vaccinations and therefore 
Travellers’ children should be targeted by GPs for catch-up vaccination to improve outcomes for 
individuals and local herd immunity.  
  
Introduction 
There are substantial health inequalities between the Traveller and non-Traveller population1 with 
the life expectancy of Travellers being 10-12 years lower than non-Traveller equivalents.2 Several 
studies have shown that there is lower vaccine uptake in Traveller children but there is a lack of 
recent, accurate data in the UK.3–5 There have been several reports of measles outbreaks originating 
in the Traveller community.6,7 Therefore, this community is at risk of vaccine-preventable diseases 
and additionally these outbreaks have spread to the non-Traveller community.8,9  Ireland, Scotland 
and Wales and pockets of England are implementing strategies to improve vaccination coverage in 
the general population, but there is no national strategy in place in England to target Traveller, 
Gypsy and Roma communities.  
The 2011 census recorded 57,680 Gypsies and Irish Travellers in England and Wales.10 However, it is 
thought that the true number is more likely to be in the region of 150,000 to 300,000 as many 
Travellers do not identify their ethnicity due to fear of discrimination.1 In 2006 it was estimated that 
11% of the Traveller population lived in the East of England forming one of the largest ethnic 
minorities in this region.11  
The aim of this audit study was to compare vaccination uptake in Traveller and non-Traveller 
children and use this information to justify the implementation of a catch-up vaccination 
programme, depending upon the results.  
Methods 
Data was extracted from the Primary Care electronic health records at a GP Practice in the East of 
England where a large proportion of patients are Irish Travellers. Database extraction took place in 
May 2015.    
Children were identified by running a report in SystmOne with the criteria “Between the age of 0 
and 17”. Travellers were identified initially by a separate report searching by “postcode begins with”, 
using the known location of permanent local Traveller sites.  Where postcodes were absent or 
incorrect, additional children known by the healthcare team to be from Traveller families were 
manually identified. 
Immunisation status was compared to the current Green Book childhood immunisation schedule.12 
As a number of changes have been made in recent years, these were reflected in the recording such 
that children born prior to the introduction of the 12 month booster for Meningitis C and Hib 
vaccines were recorded as having been vaccinated if they had all the doses recommended at the 
time. The number of children eligible for pneumococcal vaccine was taken to be any child born from 
05/09/2004 onwards as the vaccine was introduced in September 2006 along with a catch-up 
programme for children aged 2-24 months (date of birth: 05/09/2004 to 03/07/2006). Rotavirus 
vaccine was introduced in April 2013 so the number eligible was taken to be any child born from 
May 2013 onwards. Meningitis C teenage booster was introduced in September 2013 to be given in 
schools to children in year 10. Eligible children were therefore those from the current year 10 (born 
prior to September 2000) onwards.  
Vaccinations were recorded on an individual tab in SystmOne and this was used to record the 
vaccination history of all children. Vaccines were recorded as “yes” if the correct vaccination in the 
correct time period was present in the medical record. Vaccines were recorded as “no” if there was 
no medical record or if there was a documented refusal of the vaccine. As many of the travellers 
were not born in the area, tracing vaccination status prior to their registration at the practice was 
difficult. Those with uncertain vaccination histories were recorded as “no” in line with the Green 
Book recommendations that any individual with an uncertain vaccination history is treated as 
unimmunised.13 
After the initial download, data was anonymised and was not viewed by anyone outside of the 
healthcare team. 
Ethical Approval 
As this was an audit of routinely collected clinical data, ethical approval was not sought.  
Results 
A total of 1002 children (25% of total patients) were registered at the practice. Of these children, 
214 were identified as members of Irish Traveller families and 776 were non-Travellers. 12 children 
were English Travellers living in a separate location and with a different lifestyle to the Irish 
Travellers and so were excluded from statistical analysis (although they will still be contacted for 
catch-up vaccination if necessary).  
Schedule Completion 
Table 1 shows a comparison of vaccination schedule completion between Traveller and non-
Traveller children and overall herd immunity. Coverage was more than 40% lower in Traveller 
children compared to non-traveller children for completion of the vaccination schedule at all time 
points across the immunisation programme. 
Individual Vaccinations 
Table 2 shows the percentage of eligible Traveller, non-Traveller and total children completing the 
course of an individual vaccine. Coverage was over 30% lower for each individual vaccine in Traveller 
children compared to non-Traveller children.  
Figure 1 shows the cumulative percentage of Traveller and non-traveller children completing the 
primary tetanus, diphtheria, polio and pertussis course at 12-monthly increments in age from 12 
months to 18 years.  
Children past their 14th birthday are eligible to have completed the entire childhood immunisation 
schedule. Figure 2 depicts the proportion of these children who have received all the recommended 
vaccinations up to four given time points; complete baby vaccines (vaccines up to and including 4 
months), complete to 12 months, complete to pre-school (before age 5) and fully complete to 
include the teenage vaccines. ‘Fully complete’ excludes HPV and the teenage booster for Men C as 
these were introduced quite recently. Pneumococcal coverage is also not used in these figures since 
it was only introduced in 2006, when these children were all 5 years or older.   
It can be seen that completion of the immunisation schedule in Traveller infants is substantially 
below that of non-Traveller infants. This trend widens over time as the children progress into their 
teen years. 
Discussion 
Main finding of this study 
Vaccine coverage and completion of the vaccination schedule in children from this Traveller 
community is substantially lower when compared to coverage in non-Traveller children across the 
whole immunisation programme in effect at the time. 
The World Health Organization (WHO) recommends 90% national coverage for every vaccine and at 
least 80% coverage in each district or equivalent administrative unit.14 Additionally, WHO 
recommends that for measles elimination, over 95% coverage for both vaccines is needed in every 
district.15 Low coverage in the Traveller community leads to a dilution in total coverage, which, from 
this data, falls far below that recommended by WHO. Herd immunity is therefore reduced and 
outbreaks of vaccine-preventable diseases are more likely to occur. In recent years there have been 
cases of both measles and meningitis in this local Traveller community. Given that this data is from a 
single GP practice, it would not be classed as a district by WHO standards. However, this GP practice 
has a proactive and positive relationship with the large local traveller community, which may 
account for the improved coverage when compared with other studies.3-5  
Rotavirus vaccine coverage is significantly lower in the Traveller community, with less than 50% 
taking up the vaccine (Table 2). This vaccine would be particularly beneficial to Travellers as it 
protects against forms of gastroenteritis which children living on Traveller sites are more at risk of 
due to poor sanitation and hygiene.16 The rotavirus vaccine was introduced recently (April 2013) and 
may be a useful marker of the Travellers’ current beliefs and attitudes towards vaccination. There is 
clearly much work needed to improve uptake by promoting understanding and appreciation of the 
long-term benefits of vaccination. Due to low levels of literacy within the Traveller community17, 
information often spreads by word-of-mouth, potentially leading to a rapid change in vaccine uptake 
if one person in the community hears something good or bad about vaccination from, for example, 
another Traveller site.   
Figure 1 shows that timeliness of vaccination of the primary course of tetanus, diphtheria, polio and 
pertussis is reduced in the Traveller children. Overall, completion rates are higher in non-Traveller 
children. However, in both groups, cumulative percentage vaccinated is lower in the older children, 
suggesting that more of the teenagers did not complete the primary course than the younger 
children.  This indicates that vaccination coverage may be improving. Nevertheless, the reduced 
cumulative percentage between the under 24 and 48 month Traveller children remains a concern.  
Figure 2 shows that for children past their 14th birthday (and therefore eligible to have completed 
the childhood immunisation schedule), the difference in vaccine uptake widens with age. For both 
Traveller and non-Traveller children, the percentage up-to-date on vaccines decreases with 
increasing age, showing that uptake for infant vaccines is highest and for teenage vaccines is lowest.  
However, the percentage ‘fully complete’ should be treated with some caution. Although all children 
past their 14th birthday could potentially have completed the immunisation schedule, certain 
individual factors may have prevented this. For example, the fifth tetanus dose can be given from 
the age of 13 yet it must be given ten years after the fourth dose. Therefore if a child had the fourth 
dose aged 5 or older, then the time of fifth vaccination will be delayed, meaning that they will not 
have completed the childhood immunisation schedule by their 14th birthday.   
What is already known on this topic 
A recent study estimated the uptake of the third dose of polio and first dose of MMR within the 
Traveller population nationwide.4 These were used as markers to indicate coverage of the overall 
immunisation schedule. However, only 22 (16%) of the 135 Primary Care Trusts were able to provide 
an estimate of vaccine coverage in the Traveller community and of these, the majority estimated 
MMR coverage to be below 70%. Although it is acknowledged that immunisation rates are lower 
within Traveller communities, exactly how much lower they are remains unclear.  
What this study adds  
It is difficult to assess Traveller vaccine uptake accurately. This data was captured from a general 
practice where a large proportion of Travellers are registered and which adopts a proactive 
approach to engage with and provide health care to this community. Therefore this audit study has 
the potential to provide more accurate data for coverage of individual vaccines and percentage rates 
of schedule completion than previous studies.  
Our results compare favourably to those of the 1993 study in East London3 in that a higher 
percentage of children have completed both the primary tetanus course and the MMR course. This 
could either be because awareness of the benefits of vaccination has increased in the general 
population in the last two decades, or it could suggest that immunisation rates are higher in 
communities which are actively targeted by health professionals, or a combination of the two 
factors, but further research is required to elucidate this. In the 1993 study, the recording of 
immunisation status was based on opportunistic presentation to a GP or to A&E, using parental 
report or records if available, and may not reflect the case of children who had regular contact with 
healthcare professionals trusted by the community. 
Our verifiable data still shows a markedly reduced vaccine uptake within a Traveller community that 
has regular contact with a trusted practice, many of whom return to the area specifically to see the 
GP that they trust. It is likely that vaccine uptake within groups who do not have a “trusted” general 
practice is even lower.   
Limitations of this study 
There were some limitations to this audit which were unavoidable due to the lifestyle of Travellers. 
Though 214 Traveller children were identified from practice records, it is likely that there are fewer 
children than this living at the local permanent site at any particular time due to the nature of their 
travelling lifestyle. Additionally, not all children living on the site will have been registered at the 
practice and those who are unregistered are less likely to be fully vaccinated. However, due to the 
concerted efforts of the practice staff and engagement with this particular Traveller community, the 
number of unregistered children is likely to be small.   
In some cases it was difficult to confirm vaccination status. For example, in teenagers with uncertain 
vaccination history, unless there was proof that a vaccination has been given, such as the nurse 
being shown the child’s red book, then the accuracy of the information entered into the medical 
records cannot be guaranteed. In some cases, the teenage tetanus vaccine had been mis-recorded 
as the 2 month vaccination, as it was the first tetanus vaccine the child had received at the practice. 
However, given no proof of prior vaccination the child should be treated as unimmunised and the 
schedule for uncertain immunisation history should be followed.  In addition, if the vaccination 
schedule for incomplete immunisation status has not been followed and the child is just given the 
vaccine for their age, for example the Td/IPV vaccine for the teenage tetanus booster, then this may 
be interpreted to mean that the child is fully immunised when in fact, having had only one dose, 
they will not have full protection from the diseases.  
Conclusions 
This audit has highlighted a large difference in immunisation status between the Traveller and non-
Traveller children registered at a single practice and this difference has an impact on herd immunity. 
It is documented that many GPs have refused healthcare to Travellers18 whereas this particular 
practice engages with the local Traveller community, actively working with the Traveller Lead Nurse 
and the Traveller Community Development Worker appointed by the County Council. Despite these 
efforts, this audit has revealed that there is a need for discussion of the reasons for non-vaccination 
with Traveller parents in order to understand the low coverage in this community. With these 
reasons in mind, the aim would be to implement catch-up vaccination for the children who are 
currently behind in the childhood immunisation schedule and to encourage greater uptake of full-
course vaccination from the outset amongst the parents of young children in the Traveller 
population.  
If the active engagement of healthcare professionals with this local Traveller group has affected 
vaccination coverage, then these vaccination statistics are likely to be higher than in 
demographically comparable locations where general practices do not actively collaborate with 
Traveller patients, and resulting herd immunity is likely to be even lower in these areas. In line with 
the recommendations of both NICE19 and WHO14, immunisation should be targeted in areas where 
there is a lower coverage than the national average, such as communities with a significant Traveller 
population.  
Both the education of Traveller communities in terms of the benefits of vaccination, and education 
of healthcare professionals in terms of duty of care to this community may be needed to improve 
vaccination uptake.  The UNITING protocol is the first large-scale attempt to understand the reasons 
behind uptake of immunisations from both health care workers and Travellers, and hopes to be the 
first step in addressing the problem of low vaccine coverage in Traveller communities.20   
Our audit study has shown that there are inherent problems reliably identifying Traveller patients 
and their immunisation status, making the monitoring of Traveller health on a wider scale 
problematic.  The “Gypsy or Irish Traveller” subcategory was introduced in the 2011 Census. Despite 
the fact that the NHS is mandated to base ethnic monitoring on the ONS Census21, Travellers, 
Gypsies and Roma are not currently ethnic groups that are monitored by the NHS. Our findings 
strengthen the case for their inclusion. 
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Table 1: Percentage of eligible children completing the schedule to a particular time point 
 
Vaccine 
Percent Coverage (n=number eligible) 
Traveller Non-Traveller Total 
T/D/Po/Pe: Primary Course 53.1      (n=211) 94.0 (n=771) 85.2 (n=982) 
T/D/Po/Pe: Full Course (5 doses) 10.9 (n=46) 62.9 (n=159) 51.2 (n=205) 
>12 months completion 41.5 (n=200) 89.7 (n=749) 79.6 (n=949) 
>5 years completion 33.1 (n=166) 85.0 (n=574) 73.4 (n=740) 
>14 years completion 6.5  (n=46) 57.2 (n=159) 45.9 (n=205) 
MMR completion (>5years) 45.2 (n=166) 90.8 (n=574) 80.5 (n=740) 
 
n=number eligible for the vaccine 
MMR = Measles/Mumps/Rubella 
T/D/Po/Pe = Tetanus, diphtheria, polio, pertussis 
  
 Table 2: Coverage (%) for each vaccine in order of the childhood immunisation schedule 
 
Vaccine 
Percent Coverage (n=number eligible) 
Traveller Non-Traveller Total 
Rotavirus 47.6  (n=21) 92.2 (n=64) 81.2 (n=85) 
T/D/Po/Pe (2 months) 63.1      (n=214) 95.7 (n=775) 88.7 (n=989) 
T/D/Po/Pe (3 months) 59.2  (n=213) 95.0 (n=774) 87.2 (n=987) 
T/D/Po/Pe (4 months) 54.0  (n=211) 94.6 (n=772) 85.9 (n=983) 
MenC  52.0 (n=200) 91.7 (n=749) 83.4 (n=949) 
Hib 52.5 (n=200) 92.9 (n-749) 84.4 (n=949) 
Pneumococcal 47.4 (n=116) 89.2  (n=445) 80.6 (n=561) 
MMR1 54.0      (n=200) 95.5 (n=749) 86.7 (n=949) 
MMR2 46.7      (n=184) 89.3 (n=652) 79.9 (n=836) 
T/D/Po/Pe (B1) 45.7  (n=184) 89.9 (n=652) 80.1 (n=836) 
T/D/Po/Pe (B2) 15.2  (n=46) 69.2 (n=159) 57.1 (n=205) 
MenC (teenage B) 0  (n=32) 58.8 (n=131) 47.2 (n=163) 
HPV 3.6  (n=28) 81.8 (n=88) 62.9 (n=116) 
 
n=number eligible for the vaccine 
B = booster 
MenC = Meningitis C 
Hib = Haemophilus influenzae type B  
MMR = Measles/Mumps/Rubella 
T/D/Po/Pe = Tetanus, diphtheria, polio, pertussis 
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